{"id":"https://openalex.org/W4307805702","doi":"https://doi.org/10.1210/jendso/bvac150.690","title":"ODP242 Safety of SGLT2-Inhibitors in Patients with Multiple Myeloma and Diabetes","display_name":"ODP242 Safety of SGLT2-Inhibitors in Patients with Multiple Myeloma and Diabetes","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4307805702","doi":"https://doi.org/10.1210/jendso/bvac150.690"},"language":"en","primary_location":{"id":"doi:10.1210/jendso/bvac150.690","doi":"https://doi.org/10.1210/jendso/bvac150.690","is_oa":true,"landing_page_url":"https://doi.org/10.1210/jendso/bvac150.690","pdf_url":"https://academic.oup.com/jes/article-pdf/6/Supplement_1/A332/46734024/bvac150.690.pdf","source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/jes/article-pdf/6/Supplement_1/A332/46734024/bvac150.690.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040971076","display_name":"Margaret Shyu","orcid":"https://orcid.org/0000-0002-6043-6282","observed_orcids":["https://orcid.org/0000-0002-6043-6282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret Shyu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087994576","display_name":"Tracey Rosa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tracey Rosa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006580416","display_name":"Alon Yehuda Mazori","orcid":"https://orcid.org/0000-0001-5648-8269","observed_orcids":["https://orcid.org/0000-0001-5648-8269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alon Mazori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070276458","display_name":"Emily J. Gallagher","orcid":"https://orcid.org/0000-0002-7920-8474","observed_orcids":["https://orcid.org/0000-0002-7920-8474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily Gallagher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2822,"currency":"USD","value_usd":2822},"apc_paid":{"value":2822,"currency":"USD","value_usd":2822},"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.21090925,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"6","issue":"Supplement_1","first_page":"A332","last_page":"A333"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.7914999723434448,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.7914999723434448,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.16850000619888306,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9710000157356262},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8610000014305115},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.8349999785423279},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.8360000252723694},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.5659999847412109},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.453000009059906},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.5170000195503235},{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.531000018119812},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.5870000123977661},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.5730000138282776},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.5839999914169312},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.6129999756813049},{"id":"https://openalex.org/keywords/serum-creatinine","display_name":"serum creatinine","score":0.7680000066757202},{"id":"https://openalex.org/keywords/stem-cell-transplantation","display_name":"stem cell transplantation","score":0.5849999785423279},{"id":"https://openalex.org/keywords/myeloma-treatment","display_name":"myeloma treatment","score":0.34599998593330383},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8922780752182007},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.605955958366394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6026312708854675},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.5690113306045532},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.5303735733032227},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5244605541229248},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5102269649505615},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5021007061004639},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.47981026768684387},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3348292112350464},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.08444499969482422}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1210/jendso/bvac150.690","doi":"https://doi.org/10.1210/jendso/bvac150.690","is_oa":true,"landing_page_url":"https://doi.org/10.1210/jendso/bvac150.690","pdf_url":"https://academic.oup.com/jes/article-pdf/6/Supplement_1/A332/46734024/bvac150.690.pdf","source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9624880","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9624880","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Endocr Soc","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1210/jendso/bvac150.690","doi":"https://doi.org/10.1210/jendso/bvac150.690","is_oa":true,"landing_page_url":"https://doi.org/10.1210/jendso/bvac150.690","pdf_url":"https://academic.oup.com/jes/article-pdf/6/Supplement_1/A332/46734024/bvac150.690.pdf","source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4307805702.pdf","grobid_xml":"https://content.openalex.org/works/W4307805702.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4280653904","https://openalex.org/W4410804946","https://openalex.org/W4412567190","https://openalex.org/W4417009468","https://openalex.org/W7171689876","https://openalex.org/W4310109024","https://openalex.org/W7204712332","https://openalex.org/W4389231682","https://openalex.org/W4415423828","https://openalex.org/W7162662455"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"An":[2],"estimated":[3],"10-20%":[4],"of":[5,18,27,33,58,81,100,218,280,295,314,321,367,428],"patients":[6,19,44,103,125,207,244,296,396],"with":[7,20,45,75,104,131,214,397,406],"multiple":[8,278],"myeloma":[9],"(MM)":[10],"have":[11,224],"type":[12],"2":[13,38],"diabetes":[14],"(T2DM).":[15],"About":[16],"half":[17],"MM":[21,67,105,132,160,215,226,265,267,398],"will":[22],"experience":[23],"renal":[24],"insufficiency,the":[25],"risk":[26,80],"which":[28],"increases":[29],"in":[30,43,60,102,247,268,329,342,395,431],"the":[31,56,70,79,91,95,114,155,248,311,333,423],"setting":[32],"T2DM.":[34,107],"While":[35],"sodium-glucose":[36],"cotransporter":[37],"inhibitors":[39],"(SGLT2i)":[40],"are":[41,181],"beneficial":[42],"chronic":[46],"kidney":[47],"disease":[48],"(CKD)":[49],"due":[50,325],"to":[51,93,284,300,326,364,408,420],"diabetic":[52],"or":[53,129,188,230,266,349,412],"hypertensive":[54],"nephropathy,":[55],"role":[57],"SGLT2i":[59,76,101,135,166,219,233,285,301,305,387,390,429],"MM-related":[61],"CKD":[62,298],"is":[63,90,418],"unknown.":[64],"Moreover,":[65],"as":[66,85,183,382],"therapies":[68],"target":[69],"immune":[71],"system,":[72],"concurrent":[73],"use":[74],"may":[77,392],"increase":[78,328],"adverse":[82],"events":[83,323],"such":[84],"infections.":[86],"The":[87,251,287,303],"current":[88],"work":[89],"first":[92],"examine":[94],"potential":[96,424],"benefit":[97,403,425],"and":[98,106,140,163,168,170,173,177,190,192,261,277,293,310,373,399,426,437],"safety":[99,427],"Methods":[108],"This":[109],"study":[110,121],"was":[111,122,193,254,290,308,316,379,404],"approved":[112],"by":[113],"Institutional":[115],"Review":[116],"Board.":[117],"A":[118],"retrospective":[119],"cohort":[120],"performed":[123],"on":[124],"aged":[126],"18":[127],"years":[128],"older":[130],"who":[133,211],"received":[134,272],"therapy":[136,315,391,430],"between":[137],"March":[138],"2013":[139],"December":[141],"2020":[142],"at":[143,353],"a":[144,383],"quaternary":[145],"academic":[146],"medical":[147,150,164],"center.":[148],"Electronic":[149],"records":[151],"were":[152,208,212,241,245,259,324,337],"reviewed":[153],"for":[154,231,332,359,371,385],"following":[156],"data:":[157],"demographics,":[158],"comorbidities,":[159],"parameters,":[161],"medication":[162],"history,":[165],"usage":[167,234],"duration,":[169],"hemoglobin":[171],"A1c(HbA1c)":[172],"serum":[174,343,409],"creatinine":[175],"pre-":[176],"post-SGLT2i":[178],"initiation.":[179,286,302],"Data":[180],"presented":[182],"mean":[184,252,312],"\u00b1":[185],"standard":[186],"deviation":[187],"counts":[189],"percentages,":[191],"analyzed":[194],"using":[195],"SPSS":[196],"software":[197],"(version":[198],"25.":[199],"0,":[200],"IBM":[201],"Corp).":[202],"Results":[203],"In":[204],"total,":[205],"50":[206],"identified.":[209],"Patients":[210],"diagnosed":[213],"after":[216],"initiation":[217],"(n=":[220,239],"12),":[221],"did":[222],"not":[223,236,380],"any":[225,386],"data":[227],"available":[228],"(n=1),":[229],"whom":[232],"could":[235],"be":[237,393],"verified":[238],"4)":[240],"excluded.":[242],"Thirty-three":[243],"included":[246,362],"final":[249],"analysis.":[250],"age":[253],"63":[255],"(\u00b17.8)":[256],"years,":[257],"63.6%":[258],"male,":[260],"87.9%":[262],"had":[263,271,297],"active":[264],"remission.":[269],"Most":[270],"stem-cell":[273],"transplantation":[274],"(55.":[275],"0%)":[276],"lines":[279],"chemotherapy":[281],"(63.6%)":[282],"prior":[283,299],"average":[288],"HbA1c":[289],"7.4%":[291],"(\u00b11.2%)":[292],"20%":[294],"overall":[304],"discontinuation":[306,322,361],"rate":[307],"42.4%,":[309],"duration":[313],"2.2(\u00b11.5)":[317],"years.":[318],"Notably,":[319],"21.4%":[320],"an":[327],"creatinine;":[330],"however,":[331],"entire":[334],"cohort,":[335],"there":[336],"no":[338,402],"statistically":[339],"significant":[340],"changes":[341],"creatinine,":[344,410],"total":[345],"body":[346],"weight,":[347],"HbA1c,":[348,411],"24-hour":[350,413],"urine":[351,414],"protein":[352],"15":[354],"months\u2019":[355],"follow-up.":[356],"Other":[357],"reasons":[358],"SLGT2i":[360],"loss":[363],"follow-up,":[365],"change":[366],"health":[368],"insurance":[369],"coverage":[370],"SGLT2i,":[372],"unrelated":[374],"hospital":[375],"admission.":[376],"Genitourinary":[377],"infection":[378],"cited":[381],"reason":[384],"discontinuation.":[388],"Conclusion":[389],"safe":[394],"T2DM,":[400],"but":[401],"found":[405],"respect":[407],"protein.":[415],"Prospective":[416],"research":[417],"required":[419],"further":[421],"evaluate":[422],"this":[432],"population.":[433],"Presentation:":[434],"No":[435],"date":[436],"time":[438],"listed":[439]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2022-11-06T00:00:00"}